Study of the molecular mechanisms underlying endothelilal-to mesenchymal transition which promotes cancer progression
Project/Area Number |
22590283
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pathological medical chemistry
|
Research Institution | The University of Tokyo |
Principal Investigator |
WATABE Tetsuro 東京大学, 大学院・医学系研究科, 准教授 (00334235)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 癌 / 血管新生 / シグナル伝達 / 血管 |
Research Abstract |
Progression of cancer is induced by cancer associated fibroblasts (CAF). Recent reports have indicated that CAF is derived from tumor endothelial cells through endothelial-to-mesenchymal transition (EndMT). In the present study, we studied the molecular mechanisms underlying EndMT. Using MS-1 endothelial cells, I have found that activation of MRTF-A transcription factor by Rho signals is necessary for TGF-β-induced EndMT. I also found that BMP-9 and FGF enhanced and suppressed the TGF-β-induced EndMT. These results suggest that signaling cascades mediated by multiple cytokines modulate the TGF-β-induced EndMT.
|
Report
(4 results)
Research Products
(10 results)
-
-
-
-
-
-
-
-
-
-
[Presentation] Ets family members induce lymphangiogenesis via physical and functional interaction with Prox12010
Author(s)
Watabe T, Yoshimatsu Y, Mihira H, Itoh T, Yuki K, Harada K, Iwata C, Yamazaki T, Morikawa M, Miyazono K.
Organizer
The 16th International Vascular BiologyMeeting
Place of Presentation
Los Angeles, U.S.A.
Related Report